ロード中...
Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
OBJECTIVE: Therapeutic drug monitoring (TDM) enables individualization in the treatment to optimize clinical benefit and minimize drugs' side effects. Critically ill septic patients represent a challenge for antimicrobial treatment because of pathophysiological impact of sepsis on pharmacokinet...
保存先:
| 出版年: | J Basic Clin Pharm |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910469/ https://ncbi.nlm.nih.gov/pubmed/27330257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-0105.183260 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|